Paige Cofounder Thomas Fuchs’ Diagnosis on Improving Cancer Patient Outcomes With AI - Ep. 228

Improved cancer diagnostics — and improved patient outcomes — could be among the changes generative AI will bring to the healthcare industry, thanks to Paige, the first company with an FDA-approved tool for cancer diagnosis. In this episode of NVIDIA’s AI Podcast, host Noah Kravitz speaks with Paige cofounder and Chief Scientific Officer Thomas Fuchs. He’s also dean of artificial intelligence and human health at the Icahn School of Medicine at Mount Sinai. Tune in to hear Fuchs on machine learning and AI applications and how technology brings better precision and care to the medical industry.

Om Podcasten

Explore how the latest technologies are shaping our world, from groundbreaking discoveries to transformative sustainability efforts. The NVIDIA AI Podcast shines a light on the stories and solutions behind the most innovative changes, helping to inspire and educate listeners. Every week, we’ll bring you another tale, another 30-minute interview, as we build a real-time oral history of AI that’s already garnered nearly 6.5 million listens and been acclaimed as one of the best AI and machine learning podcasts. Listen in and get inspired. More information: https://ai-podcast.nvidia.com/